Structural basis for the recognition of cellular mRNA export factor REF by herpes viral proteins HSV-1 ICP27 and HVS ORF57.
The herpesvirus proteins HSV-1 ICP27 and HVS ORF57 promote viral mRNA export by utilizing the cellular mRNA export machinery. This function is triggered by binding to proteins of the transcription-export (TREX) complex, in particular to REF/Aly which directs viral mRNA to the TAP/NFX1 pathway and, subsequently, to the nuclear pore for export to the cytoplasm. Here we have determined the structure of the REF-ICP27 interaction interface at atomic-resolution and provided a detailed comparison of the binding interfaces between ICP27, ORF57 and REF using solution-state NMR. Despite the absence of any obvious sequence similarity, both viral proteins bind on the same site of the folded RRM domain of REF, via short but specific recognition sites. The regions of ICP27 and ORF57 involved in binding by REF have been mapped as residues 104-112 and 103-120, respectively. We have identified the pattern of residues critical for REF/Aly recognition, common to both ICP27 and ORF57. The importance of the key amino acid residues within these binding sites was confirmed by site-directed mutagenesis. The functional significance of the ORF57-REF/Aly interaction was also probed using an ex vivo cytoplasmic viral mRNA accumulation assay and this revealed that mutants that reduce the protein-protein interaction dramatically decrease the ability of ORF57 to mediate the nuclear export of intronless viral mRNA. Together these data precisely map amino acid residues responsible for the direct interactions between viral adaptors and cellular REF/Aly and provide the first molecular details of how herpes viruses access the cellular mRNA export pathway.
Faculty of Life Sciences and Manchester Interdisciplinary Biocentre, University of Manchester, Manchester, United Kingdom.
Richard B
RB
Tunnicliffe
Guillaume M
GM
Hautbergue
Priti
P
Kalra
Brian R
BR
Jackson
Adrian
A
Whitehouse
Stuart A
SA
Wilson
Alexander P
AP
Golovanov
D000595:Amino Acid Sequence; D001665:Binding Sites; D043603:DNA-(Apurinic or Apyrimidinic Site) Lyase / Q000737:chemistry / Q000378:metabolism*; D005090:Exodeoxyribonucleases / Q000378:metabolism; D018259:Herpesvirus 1, Human / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D017874:Immediate-Early Proteins / Q000737:chemistry / Q000378:metabolism*; D008969:Molecular Sequence Data; D010750:Phosphoproteins / Q000378:metabolism; D011485:Protein Binding; D025941:Protein Interaction Mapping; D012333:RNA, Messenger / Q000378:metabolism*; D012367:RNA, Viral / Q000737:chemistry / Q000378:metabolism*; D012097:Repressor Proteins / Q000737:chemistry / Q000378:metabolism*; D015534:Trans-Activators / Q000737:chemistry / Q000378:metabolism*
C057120:ICP27 protein, human herpesvirus 1; D017874:Immediate-Early Proteins; C415247:ORF57 protein, Herpesvirus saimiri; D010750:Phosphoproteins; D012333:RNA, Messenger; D012367:RNA, Viral; D012097:Repressor Proteins; D015534:Trans-Activators; D005090:Exodeoxyribonucleases; C429526:three prime repair exonuclease 1; C085108:APEX1 protein, human; D043603:DNA-(Apurinic or Apyrimidinic Site) Lyase
J Virol. 1998 Jan;72(1):857-61
9420300
J Biol Chem. 2001 Jun 8;276(23):19905-12
11278515
J Biomol NMR. 1999 Mar;13(3):289-302
10212987
J Biol Chem. 2003 Jan 3;278(1):335-42
12403791
RNA. 2006 Nov;12(11):1933-48
17000901
Trends Cell Biol. 2003 Jun;13(6):319-27
12791298
J Virol. 2009 Feb;83(3):1184-92
19019956
J Gen Virol. 2009 Jun;90(Pt 6):1455-1460
19264631
Front Biosci. 2008 Jan 01;13:2928-38
17981766
J Virol. 2009 Jul;83(13):6727-38
19369342
Nat Struct Mol Biol. 2006 Sep;13(9):839-48
16936729
J Gen Virol. 1997 Dec;78 ( Pt 12):3327-31
9400984
Nat Struct Mol Biol. 2007 Jul;14(7):620-9
17589525
Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5154-9
18364396
J Virol. 2009 Sep;83(17):8970-5
19553338
Electrophoresis. 1997 Dec;18(15):2714-23
9504803
Genes Dev. 2004 Jul 1;18(13):1513-26
15231733
J Virol. 2009 Jul;83(13):6335-46
19369354
J Virol. 2010 Mar;84(5):2212-22
20015986
Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15190-5
17005724
EMBO J. 2006 Nov 1;25(21):5126-37
17036044
EMBO J. 2003 Apr 1;22(7):1608-19
12660167
Curr Biol. 2009 Dec 1;19(22):1918-24
19836239
Biochem Biophys Res Commun. 2010 Jan 1;391(1):322-8
19913501
Biochem J. 2005 Apr 15;387(Pt 2):295-308
15537388
RNA. 2000 Apr;6(4):638-50
10786854
Curr Biol. 2002 May 14;12(10):859-62
12015125
Front Biosci. 2008 May 01;13:5241-56
18508584
EMBO Rep. 2007 Aug;8(8):756-62
17668007
J Biomol NMR. 1995 Nov;6(3):277-93
8520220
J Gen Virol. 2009 Mar;90(Pt 3):596-601
19218204
EMBO J. 2010 Jun 2;29(11):1851-64
20436455
Methods Mol Biol. 2004;278:353-78
15318003
EMBO J. 2001 Oct 15;20(20):5769-78
11598019
J Virol. 2002 Nov;76(22):11612-22
12388722
Curr Opin Struct Biol. 2008 Jun;18(3):290-8
18515081
Cell. 2001 Sep 7;106(5):595-605
11551507
J Virol. 1999 Dec;73(12):10519-24
10559371
J Virol. 1996 Nov;70(11):7445-53
8892862
PLoS Pathog. 2008 Oct;4(10):e1000194
18974867
Biochemistry. 2003 Jun 24;42(24):7348-57
12809490
J Biol Chem. 2004 Jul 30;279(31):33001-11
15155762
J Virol. 2005 Apr;79(7):3949-61
15767397
Traffic. 2009 Sep;10(9):1199-208
19552647
FEBS Lett. 2009 Nov 19;583(22):3549-56
19850040
J Virol. 1995 Feb;69(2):935-47
7529337
J Cell Sci. 2009 Jun 15;122(Pt 12):1933-7
19494120
Mol Cell. 2001 Sep;8(3):645-56
11583626
J Biomol NMR. 2006;36 Suppl 1:41
16738786
J Virol. 2002 Dec;76(24):12877-89
12438613
J Virol. 1994 Dec;68(12):7790-9
7966568
J Virol. 2002 Dec;76(23):11866-79
12414929
Genes Dev. 1998 Mar 15;12(6):868-79
9512520